L-Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 4, 2003, Pages 1065-1070

  Kown, Murray H ^a   Lijkwan, Maarten A ^a   Jahncke, Christina L ^a   Murata, Seiichiro ^a   Rothbard, Jonathan B ^b   Robbins, Robert C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cellgate Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; NITRIC OXIDE; PHOSPHATE; POLYMER; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART MUSCLE; HEART PROTECTION; HEART SURGERY; HEART TRANSPLANTATION; HISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0142213853     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00354-4     Document Type: Article

References (32)

1. Masini E, Salvemini D, Ndisang JF, et al. Cardioprotective activity of endogenous and exogenous nitric oxide on ischaemia reperfusion injury in isolated guinea pig hearts. Inflamm Res. 1999;48:561-8.
2. Park JL, Lucchesi BR. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg. 1999;68:1905-12.
3. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Botelho LH. Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun. 1991;181:1392-7.
4. Vinten-Johansen J, Sato H, Zhao ZQ. The role of nitric oxide and NO-donor agents in myocardial protection from surgical ischemic-reperfusion injury. Int J Cardiol. 1995;50:273-81.
5. Pabla R, Buda AJ, Flynn DM, et al. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ Res. 1996;78:65-72.
6. Goumas G, Tentolouris C, Tousoulis D, Stefanadis C, Toutouzas P. Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases. Atherosclerosis. 2001;154:255-67.
7. Salas A, Gironella M, Soriano A, et al. Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice. Lab Invest. 2002;82:597-607.
8. von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A. 1995;92:1137-41.
9. Okazaki J, Komori K, Kawasaki K, Eguchi D, Ishida M, Sugimachi K. L-Arginine inhibits smooth muscle cell proliferation of vein graft intimal thickness in hypercholesterolemic rabbits. Cardiovasc Res. 1997;36:429-36.
10. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res. 2000;56:318-25.
11. Kown MH, van der Steenhoven T, Uemura S, et al. L-Arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation. Transplantation. 2001;71:1542-8.
12. Gurevitch J, Frolkis I, Yuhas Y, et al. Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol. 1996;28:247-52.
13. Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274:R577-95.
14. Hill CM, Liu A, Marshall KW, et al. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 1994;152:2890-8.
15. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 1969;57:225-9.
16. Kobayashi N, Kobayashi K, Kouno K, Horinaka S, Yagi S. Effects of intra-atrial injection of colored microspheres on systemic hemodynamics and regional blood flow in rats. Am J Physiol. 1994;266:H1910-7.
17. Efthymiadis A, Briggs LJ, Jans DA. The HIV-1 Tat nuclear localization sequence confers novel nuclear import properties. J Biol Chem. 1998;273:1623-8.
18. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997;272:16010-7.
19. Uemura S, Fathman CG, Rothbard JB, Cooke JP. Rapid and efficient vascular transport of arginine polymers inhibits myointimal hyperplasia. Circulation. 2000;102:2629-35.
20. Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med. 1996;47:365-75.
21. Knight RJ, Dikman S, Liu H, Martinelli GP. Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model. Transplantation. 1997;64:1102-7.
22. Lemmer JHJ, Kirsh MM. Coronary artery spasm following coronary artery surgery. Ann Thorac Surg. 1988;46:108-15.
23. Jost S, Sturm M, Hausmann D, Lippolt P, Lichtlen PR. Standardization of coronary vasomotor tone with intracoronary nitroglycerin. Am J Cardiol. 1996;78:120-3.
24. Ishihara M, Sato H, Tateishi H, et al. Effects of various doses of intracoronary diltiazem on coronary resistance vessels in humans. Jpn Circ J. 1995;59:790-8.
25. Agullo L, Garcia-Dorado D, Inserte J, et al. L-Arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism. Am J Physiol. 1999;276:H1574-80.
26. Mizuno T, Watanabe M, Sakamoto T, Sunamori M. L-Arginine, a nitric oxide precursor, attenuates ischemia-reperfusion injury by inhibiting inositol-1,4.5-triphosphate. J Thorac Cardiovasc Surg. 1998;115:931-6.
27. Yan Y, Davani S, Chocron S, Kantelip B, Muret P, Kantelip JP. Effects of L-arginine administration before cardioplegic arrest on ischemia-reperfusion injury. Ann Thorac Surg. 2001;72:1985-90.
28. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB. Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res. 2000;56:318-25.
29. Kibbe M, Billiar T, Tzeng E. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res. 1999;43:650-7.
30. Weyrich AS, Ma XL, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation. 1992;86:279-88.
31. Lass A, Suessenbacher A, Wolkart G, Mayer B, Brunner F. Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. Mol Pharmacol. 2002;61:1081-8.
32. Dinarello CA, Cannon JG, Wolff SM, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986;163:1433-50.